Skip to main content

Advertisement

SpringerLink
Log in

Outcomes following cardiac transplantation in adults

  • Review Article
  • Published:
Indian Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

For a carefully selected group of patients with advanced heart failure where prognosis and quality of life remain poor, cardiac transplantation is the treatment of choice. Long-term survival and quality of life are now excellent in most patients post-transplantation, but important short- and long-term complications remain a significant concern. The mainstay of early and longer term post-transplant care is the surveillance for and treatment of these complications. This review article provides an overview of the contemporary outcomes after heart transplant, the more commonly encountered problems and their management in the early and late stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jones DS, Sivaramakrishnan K. Transplant Buccaneers: P.K. Sen and India's First Heart Transplant, February 1968. J Hist Med Allied Sci. 2018;73:303–32. https://doi.org/10.1093/jhmas/jrx059.

    Article  PubMed  Google Scholar 

  2. Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report—2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant. 2018;37:1155–68. https://doi.org/10.1016/j.healun.2018.07.022.

    Article  PubMed  Google Scholar 

  3. NHSBT. Annual Report on Cardiothoracic Organ Transplantation 2016/17, NHS Blood and Transplant. 2017. https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/5418/cardiothoracicannual-report-2016-17.pdf. Accessed 06/05/2018 2018.

  4. Truby LK, Takeda K, Topkara VK, et al. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018;37:1433–42. https://doi.org/10.1016/j.healun.2018.07.013.

    Article  PubMed  Google Scholar 

  5. Grady KL, Naftel DC, Kobashigawa J, et al. Patterns and predictors of quality of life at 5 to 10 years after heart transplantation. J Heart Lung Transplant. 2007;26:535–43.

    Article  Google Scholar 

  6. Kobashigawa J, Zuckermann A, Macdonald P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 2014;33:327–40. https://doi.org/10.1016/j.healun.2014.02.027.

    Article  PubMed  Google Scholar 

  7. Squiers JJ, Saracino G, Chamogeorgakis T, et al. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre. Eur J Cardiothorac Surg. 2017;51:263–70. https://doi.org/10.1093/ejcts/ezw271.

    Article  PubMed  Google Scholar 

  8. Avtaar Singh SS, Banner NR, Rushton S, Simon AR, Berry C, Al-Attar N. ISHLT Primary Graft Dysfunction incidence, risk factors and outcome: a UK National Study. Transplantation. 2018. https://doi.org/10.1097/TP.0000000000002220.

  9. Sabatino M, Vitale G, Manfredini V, et al. Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes. J Heart Lung Transplant. 2017;36:1217–25. https://doi.org/10.1016/j.healun.2017.02.014.

    Article  PubMed  Google Scholar 

  10. Segovia J, Cosio MD, Barcelo JM, et al. RADIAL: a novel primary graft failure risk score in heart transplantation. J Heart Lung Transplant. 2011;30:644–51. https://doi.org/10.1016/j.healun.2011.01.721.

    Article  PubMed  Google Scholar 

  11. Cosio Carmena MD, Gomez Bueno M, Almenar L, et al. Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score. J Heart Lung Transplant. 2013;32:1187–95. https://doi.org/10.1016/j.healun.2013.08.004.

    Article  PubMed  Google Scholar 

  12. Nicoara A, Ruffin D, Cooter M, et al. Primary graft dysfunction after heart transplantation: Incidence, trends. and associated risk factors. Am J Transplant. 2017;18:1461–70. https://doi.org/10.1111/ajt.14588.2.

    Article  PubMed  Google Scholar 

  13. Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–56. https://doi.org/10.1016/j.healun.2010.05.034.

    Article  PubMed  Google Scholar 

  14. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710–20.

    Article  Google Scholar 

  15. Lund LH, Khush KK, Cherikh WS, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017;36:1037–46. https://doi.org/10.1016/j.healun.2017.07.019.

    Article  PubMed  Google Scholar 

  16. Jarcho J, Naftel DC, Shroyer TW, et al. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13:583–95.

    CAS  PubMed  Google Scholar 

  17. Fitzsimons S, Evans J, Parameshwar J, Pettit SJ. Utility of troponin assays for exclusion of acute cellular rejection after heart transplantation: A systematic review. J Heart Lung Transplant. 2018;37:631–8. https://doi.org/10.1016/j.healun.2017.12.008.

    Article  PubMed  Google Scholar 

  18. Soderlund C, Ohman J, Nilsson J, et al. Acute cellular rejection the first year after heart transplantation and its impact on survival: a single-centre retrospective study at Skane University Hospital in Lund 1988-2010. Transpl Int. 2014;27:482–92. https://doi.org/10.1111/tri.12284.

  19. Chih S, Chong AY, Mielniczuk LM, Bhatt DL, Beanlands RS. Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation. J Am Coll Cardiol. 2016;68:80–91. https://doi.org/10.1016/j.jacc.2016.04.033.

    Article  PubMed  Google Scholar 

  20. Crespo-Leiro MG, Stypmann J, Schulz U, et al. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Eur Heart J. 2016;37:2591–601. https://doi.org/10.1093/eurheartj/ehv682.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010;362:1890–900. https://doi.org/10.1056/NEJMoa0912965.

    Article  CAS  PubMed  Google Scholar 

  22. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant. 2006;25:153–9.

    Article  Google Scholar 

  23. Colvin MM, Cook JL, Chang P, et al. Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2015;131:1608–39. https://doi.org/10.1161/CIR.0000000000000093.

    Article  PubMed  Google Scholar 

  24. Almuti K, Haythe J, Dwyer E, et al. The changing pattern of humoral rejection in cardiac transplant recipients. Transplantation. 2007;84:498–503.

    Article  Google Scholar 

  25. Clerkin KJ, Restaino SW, Zorn E, Vasilescu ER, Marboe CC, Mancini DM. The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibodymediated rejection. J Heart Lung Transplant. 2016;35:1059–66. https://doi.org/10.1016/j.healun.2016.04.007.3.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Coutance G, Ouldamar S, Rouvier P, et al. Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy. J Heart Lung Transplant. 2015;34:1050–7. https://doi.org/10.1016/j.healun.2015.03.002.

    Article  PubMed  Google Scholar 

  27. Kobashigawa J, Colvin M, Potena L, et al. The management of antibodies in heart transplantation: An ISHLT consensus document. J Heart Lung Transplant. 2018;37:537–47. https://doi.org/10.1016/j.healun.2018.01.1291.

    Article  PubMed  Google Scholar 

  28. De Vlaminck I, Valantine HA, Snyder TM, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014;6:241ra77. https://doi.org/10.1126/scitranslmed.3007803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Agbor-Enoh S, Tunc I, De Vlaminck I, et al. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. J Heart Lung Transplant. 2017;36:1004–12. https://doi.org/10.1016/j.healun.2017.05.026.

    Article  PubMed  Google Scholar 

  30. van de Beek D, Kremers WK, Del Pozo JL, et al. Effect of infectious diseases on outcome after heart transplant. Mayo Clin Proc. 2008;83:304–8. https://doi.org/10.4065/83.3.304.

    Article  PubMed  Google Scholar 

  31. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601–14.

    Article  CAS  Google Scholar 

  32. Gupta S, Mitchell JD, Markham DW, et al. Utility of the Cylex assay in cardiac transplant recipients. J Heart Lung Transplant. 2008;27:817–22. https://doi.org/10.1016/j.healun.2008.05.014.

    Article  PubMed  Google Scholar 

  33. Kobashigawa JA, Kiyosaki KK, Patel JK, et al. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes. J Heart Lung Transplant. 2010;29:504–8. https://doi.org/10.1016/j.healun.2009.12.015.

    Article  PubMed  Google Scholar 

  34. Mehra MR. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant. 2006;6:1248–56.

    Article  CAS  Google Scholar 

  35. Brunner-La Rocca HP, Schneider J, Kunzli A, Turina M, Kiowski W. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease. Transplantation. 1998;65:538–43.

    Article  CAS  Google Scholar 

  36. Luk A, Alba AC, Butany J, Tinckam K, Delgado D, Ross HJ. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients. Transpl Int. 28:857–63. https://doi.org/10.1111/tri.12560.

  37. Frank R, Molina MR, Goldberg LR, Wald JW, Kamoun M, Lal P. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy. Am J Clin Pathol. 2014;142:809–15.

    Article  Google Scholar 

  38. Kobashigawa JA, Itagaki BK, Razi RR, et al. Correlation between myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation. Clin Transplant. 2013;27:E679–84. https://doi.org/10.1111/ctr.12250.

    Article  PubMed  Google Scholar 

  39. Mehra MR, Crespo-Leiro MG, Dipchand A, et al. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010;29:717–27. https://doi.org/10.1016/j.healun.2010.05.017.

    Article  PubMed  Google Scholar 

  40. Luc JGY, Choi JH, Rizvi SA, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in heart transplant recipients with coronary allograft vasculopathy: a systematic review and meta-analysis of 1,520 patients. Ann Cardiothorac Surg. 2018;7:19–30. https://doi.org/10.21037/acs.2018.01.10.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621–7.

    Article  CAS  Google Scholar 

  42. Goldraich LA, Stehlik J, Kucheryavaya AY, Edwards LB, Ross HJ. Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis. Am J Transplant. 2016;16:301–9. https://doi.org/10.1111/ajt.13418.

    Article  CAS  PubMed  Google Scholar 

  43. Keogh A, Richardson M, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation. 2004;110:2694–700.

    Article  CAS  Google Scholar 

  44. Kobashigawa JA, Pauly DF, Starling RC, et al. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial. JACC Heart Fail. 2013;1:389–99. https://doi.org/10.1016/j.jchf.2013.07.002.

    Article  PubMed  Google Scholar 

  45. Lindenfeld J, Page RL 2nd, Zolty R, et al. Drug therapy in the heart transplant recipient: Part III: common medical problems. Circulation. 2005;111:113–7.

    Article  Google Scholar 

  46. Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc. 2001;6:207–11.

    Article  CAS  Google Scholar 

  47. Crespo-Leiro MG, Alonso-Pulpon L, Vazquez de Prada JA, et al. Malignancy after heart transplantation: incidence, prognosis and risk factors. Am J Transplant. 2008;8:1031–9. https://doi.org/10.1111/j.1600-6143.2008.02196.x.

    Article  CAS  PubMed  Google Scholar 

  48. Kumarasinghe G, Lavee O, Parker A, et al. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors. J Heart Lung Transplant. 2015;34:1406–14. https://doi.org/10.1016/j.healun.2015.05.021.

    Article  PubMed  Google Scholar 

  49. Hertig A, Zuckermann A. Rabbit antithymocyte globulin induction and risk of posttransplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update. Transpl Immunol. 2015;32:179–87. https://doi.org/10.1016/j.trim.2015.04.003.

    Article  CAS  PubMed  Google Scholar 

  50. Youn JC, Stehlik J, Wilk AR, et al. Temporal Trends of De Novo Malignancy Development After Heart Transplantation. J Am Coll Cardiol. 2018;71:40–9. https://doi.org/10.1016/j.jacc.2017.10.077.

    Article  PubMed  Google Scholar 

  51. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931–40.

    Article  CAS  Google Scholar 

  52. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4:481–508. https://doi.org/10.2215/CJN.04800908.

    Article  CAS  PubMed  Google Scholar 

  53. Zuckermann A, Keogh A, Crespo-Leiro MG, et al. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant. 2012;12:2487–97. https://doi.org/10.1111/j.1600-6143.2012.04131.x.

    Article  CAS  PubMed  Google Scholar 

  54. Andreassen AK, Andersson B, Gustafsson F, et al. Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study. Am J Transplant. 2016;16:1238–47. https://doi.org/10.1111/ajt.13588.

    Article  CAS  PubMed  Google Scholar 

  55. Radovancevic B, Poindexter S, Birovljev S et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg. 1990;4:309–12.

  56. Ozdogan E, Banner N, Fitzgerald M, Musumeci F, Khaghani A, Yacoub M. Factors influencing the development of hypertension after heart transplantation. J Heart Transplant. 1990;9:548–53.

    CAS  PubMed  Google Scholar 

  57. Shah MK, Critchley WR, Yonan N, Williams SG, Shaw SM. Second line options for hyperlipidemia management after cardiac transplantation. Cardiovasc Ther. 2013;31:138–46. https://doi.org/10.1111/j.1755-5922.2012.00315.x.

    Article  CAS  PubMed  Google Scholar 

  58. Lindenfeld J, Miller GG, Shakar SF, et al. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation. 2004;110:3858–65.

    Article  CAS  Google Scholar 

  59. Mogollon Jimenez MV, Sobrino Marquez JM, Arizon Munoz JM, et al. Incidence and importance of de novo diabetes mellitus after heart transplantation. Transplant Proc. 2008;40:3053–5. https://doi.org/10.1016/j.transproceed.2008.09.045.

    Article  CAS  PubMed  Google Scholar 

  60. Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin North Am. 2007;36:937–63.

    Article  CAS  Google Scholar 

  61. Bhagra CJ, Bhagra SK, Donado A, et al. Pregnancy in cardiac transplant recipients. Clin Transplant. 2016;30:1059–65. https://doi.org/10.1111/ctr.12788.

    Article  CAS  PubMed  Google Scholar 

  62. Dhital KK, Iyer A, Connellan M, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series. Lancet. 2015;385:2585–91. https://doi.org/10.1016/S0140-6736(15)60038-1.

    Article  PubMed  Google Scholar 

  63. Messer S, Page A, Axell R, et al. Outcome after heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant. 2017;36:1311–8. https://doi.org/10.1016/j.healun.2017.10.021.

    Article  PubMed  Google Scholar 

  64. Garcia Saez D, Zych B, Sabashnikov A, et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. Ann Thorac Surg. 2014;98:2099–105. https://doi.org/10.1016/j.athoracsur.2014.06.098.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Transplant Unit, Royal Papworth Hospital, Papworth Everard, Cambridge, CB23 3RE, UK

    Sai Bhagra & Jayan Parameshwar

Authors
  1. Sai Bhagra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jayan Parameshwar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sai Bhagra.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

Not applicable as this is a review article.

Informed consent

Not applicable as this is a review article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhagra, S., Parameshwar, J. Outcomes following cardiac transplantation in adults. Indian J Thorac Cardiovasc Surg 36 (Suppl 2), 166–174 (2020). https://doi.org/10.1007/s12055-019-00796-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12055-019-00796-0

Keywords

Search

Navigation